SCHEMBL1003887

SCHEMBL1003887

C=CC(=O)C(C[N+](C)(C)C)OP(=O)([O-])O

nearest known ligand 0.32

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
SLC22A16 Q86VW1 1/20 0.31
TSHR P16473 1/20 0.30
CHRM2 P08172 1/20 0.30
CHRM4 P08173 1/20 0.30
CHRM1 P11229 1/20 0.30
TBXA2R P21731 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8910736 0.80 LAP3 (0.37) SLC22A16TSHRCHRM2CHRM4CHRM1
SCHEMBL338774 0.77 MEN1 (0.36) SLC22A16TSHRCHRM2CHRM4CHRM1
SCHEMBL4550499 0.73 TSHR (0.37) SLC22A16TSHRCHRM2CHRM4CHRM1
SCHEMBL65990 0.72 MEN1 (0.33) TSHR
SCHEMBL3263237 0.72
Hydrochloric Acid SCHEMBL27882963 0.71 MAPT (0.39) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL1260408 0.71 TSHR (0.37) TSHR
SCHEMBL17076293 0.70 TSHR (0.34) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL5190821 0.70 MAPT (0.44) TSHR
SCHEMBL30673761 0.70 MAPT (0.44) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9750847-B2 Chitosan hydrogel derivatives as a coating agent with broad spectrum of antimicrobial activities NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2017-09-05 US disclosed
US-20160038636-A1 CHITOSAN HYDROGEL DERIVATIVES AS A COATING AGENT WITH BROAD SPECTRUM OF ANTIMICROBIAL ACTIVITIES NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2016-02-11 US disclosed
EP-2454286-B1 CHITOSAN HYDROGEL DERIVATIVES AS A COATING AGENT WITH BROAD SPECTRUM OF ANTIMICROBIAL ACTIVITIES MENICON CO LTD (JP) 2015-12-16 EP disclosed
US-9199000-B2 Chitosan hydrogel derivatives as a coating agent with broad spectrum of antimicrobial activities NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2015-12-01 US disclosed
US-20140193476-A1 CHITOSAN HYDROGEL DERIVATIVES AS A COATING AGENT WITH BROAD SPECTRUM OF ANTIMICROBIAL ACTIVITIES NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2014-07-10 US disclosed
US-8709470-B2 Chitosan hydrogel derivatives as a coating agent with broad spectrum of antimicrobial activities MENICON CO., LTD. (JP) 2014-04-29 US disclosed
US-20120164208-A1 CHITOSAN HYDROGEL DERIVATIVES AS A COATING AGENT WITH BROAD SPECTRUM OF ANTIMICROBIAL ACTIVITIES NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2012-06-28 US disclosed
EP-2454286-A1 CHITOSAN HYDROGEL DERIVATIVES AS A COATING AGENT WITH BROAD SPECTRUM OF ANTIMICROBIAL ACTIVITIES Menicon Co., Ltd. (JP) 2012-05-23 EP disclosed
WO-2011007454-A1 CHITOSAN HYDROGEL DERIVATIVES AS A COATING AGENT WITH BROAD SPECTRUM OF ANTIMICROBIAL ACTIVITIES MENICON CO., LTD. (JP) 2011-01-20 WO disclosed
US-7064174-B2 Silicon containing compounds BIOCOMPATIBLES UK LIMITED (GB) 2006-06-20 US disclosed
EP-1255761-B1 SILICON CONTAINING COMPOUNDS FROM MICHAEL - TYPE ADDITION REACTIONS USEFUL AS MONOMERS AND MACROMERS BIOCOMPATIBLES UK LTD (GB) 2005-08-31 EP disclosed
US-6828029-B1 Biocompatibility, hemocompatibility; coatings, contact and intraocular lenses, blood contacting devices; phospholipid analogues BIOCOMPATIBLES UK LIMITED (GB) 2004-12-07 US disclosed
EP-1122258-B1 Silicon containing compounds from Michael-type adduct reactions useful as monomers and macromers BIOCOMPATIBLES UK LTD (GB) 2004-05-12 EP disclosed
US-20030152786-A1 Silicon containing compounds from michael-type addition reactions useful as monomers and macromers BIOCOMPATIBLES UK LIMITED (GB) 2003-08-14 US disclosed
EP-1255761-A1 SILICON CONTAINING COMPOUNDS FROM MICHAEL - TYPE ADDITION REACTIONS USEFUL AS MONOMERS AND MACROMERS BIOCOMPATIBLES LTD. (GB) 2002-11-13 EP disclosed
WO-2001057047-A1 ZWITTERIONIC GROUPS CONTAINING COMPOUNDS FROM MICHAEL-TYPE REACTIONS USEFUL AS MONOMERS AND MACROMERS BIOCOMPATIBLES UK LIMITED (GB) 2001-08-09 WO disclosed
WO-2001057048-A1 SILICON CONTAINING COMPOUNDS FROM MICHAEL - TYPE ADDITION REACTIONS USEFUL AS MONOMERS AND MACROMERS BIOCOMPATIBLES LIMITED (GB) 2001-08-09 WO disclosed
EP-1122258-A1 Silicon containing compounds from Michael-type adduct reactions useful as monomers and macromers BIOCOMPATIBLES LIMITED (GB) 2001-08-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160038636-A1 CHITOSAN HYDROGEL DERIVATIVES AS A COATING AGENT WITH BROAD SPECTRUM OF ANTIMICROBIAL ACTIVITIES ACMSD, CDC37, USP30 SLC22A16 4073/4885TSHR 3034/4885CHRM2 2946/4885
US-20140193476-A1 CHITOSAN HYDROGEL DERIVATIVES AS A COATING AGENT WITH BROAD SPECTRUM OF ANTIMICROBIAL ACTIVITIES ACMSD, CDC37, USP30 SLC22A16 4073/4885TSHR 3034/4885CHRM2 2946/4885
US-20120164208-A1 CHITOSAN HYDROGEL DERIVATIVES AS A COATING AGENT WITH BROAD SPECTRUM OF ANTIMICROBIAL ACTIVITIES CRYZ, CRYAA, USP30 SLC22A16 4436/4885TSHR 1735/4885CHRM2 1753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.